ResMed | RMD - Trade Debtors


ResMed reported $998.84M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Ansell USD 231.1M 15.4M Dec/2025
Artivion USD 103.68M 6.31M Dec/2025
AtriCure USD 71.31M 4.66M Mar/2026
Baxter International USD 1.7B 310M Mar/2026
Cochlear AUD 568.4M 17.5M Dec/2025
Cooper Companies USD 809.2M 2.1M Mar/2026
CSL USD 4.32B 1.35B Dec/2025
Dexcom USD 1.09B 182.1M Mar/2026
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
Fisher Paykel Healthcare NZD 335.7M 16.5M Dec/2025
Globus Medical USD 735.44M 8.23M Mar/2026
Haemonetics USD 195.71M 11.36M Dec/2025
Idexx Laboratories USD 697.21M 144.83M Mar/2026
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 544.7M 27.8M Mar/2026
Integra LifeSciences USD 264.41M 14.44M Mar/2026
Intuitive Surgical USD 1.6B 68.3M Mar/2026
Masimo USD 288.9M 103M Mar/2026
Medtronic USD 6.36B 30M Dec/2025
Philips EUR 3.53B 273M Mar/2026
Ramsay Health Care AUD 2.48B 22.3M Dec/2025
ResMed USD 998.84M 13.2M Mar/2026
Sigma Healthcare AUD 2.56B 2.23B Dec/2025
Sonic Healthcare AUD 1.39B 23.76M Dec/2024
Steris USD 1.09B 102.2M Mar/2026
Teleflex USD 365.53M 19.94M Mar/2026
Thermo Fisher Scientific USD 9.2B 304M Mar/2026